## Abstract Both arsenic and benzo[__a__]pyrene (BaP) inhibit terminal differentiation and alter growth potential in normal human epidermal keratinocytes (NHEK) __in vitro__. To identify molecular alterations that may be involved in these cellular processes, microarray analysis was carried out on N
Gene expression of normal human epidermal keratinocytes modulated by trivalent arsenicals
β Scribed by Kathryn A. Bailey; Susan D. Hester; Geremy W. Knapp; Russell D. Owen; Sheau-Fung Thai
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 624 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.20677
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Chronic exposure to inorganic arsenic (iAs) is associated with the development of benign and malignant human skin lesions including nonmelanoma skin cancers. The precise arsenical form(s) responsible for this carcinogenic effect are unknown, although trivalent inorganic arsenic (iAs^III^) and two of its toxic metabolites, monomethylarsonous acid (MMA^III^) and methylarsinous acid (DMA^III^), are attractive candidates. In an effort to better understand and compare their toxic effects in the skin, we compared the global gene expression profiles of normal human epidermal keratinocytes (NHEKs) exposed to varying noncytotoxic/slightly cytotoxic concentrations of iAs^III^, MMA^III^, and DMA^III^ for 24βh. Exposure to each arsenical treatment group exhibited a dose effect in the number of altered genes and the magnitude of expression change in NHEKs. The most significant gene expression changes associated with iAs^III^ and MMA^III^ exposure were consistent with several key events believed to be important to Asβdriven skin carcinogenesis, namely induction of oxidative stress, increased transcript levels of keratinocyte growth factors, and modulation of MAPK and NFβΞΊB pathways. At both comparable arsenical concentrations and comparable NHEK toxicity, greater potential carcinogenic effects were observed in MMA^III^βexposed NHEKs than those exposed to iAs^III^, including involvement of more proinflammatory signals and increased transcript levels of more growth factor genes. In contrast, none of these aboveβmentioned transcriptional trends were among the most significantly altered functions in the DMA^III^ treatment group. This study suggests the relative capacity of each of the tested arsenicals to drive suspected key events in Asβmediated skin carcinogenesis is MMA^III^β>βiAs^III^ with little contribution from DMA^III^. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
The functional role of epidermal growth factor (EGF) in epithelium-derived human colonic carcinoma cells was investigated by transfection with plasmid pUCDS3, which contained synthetic human EGF encoding sequences, into two human colonic carcinoma cell types with dissimilar phenotypic properties: th
Expression of the transglutaminase type1 gene (TGM1), which encodes an epithelial cell-specific protein cross-linking enzyme, is limited to particular stages of epidermal development and keratinocyte differentiation. As a result, transglutaminase type 1 (TGase1) enzyme activity in epidermal cells in
The effect of transforming growth factor-type f3 l(TGF-P) on the growth and differentiation of normal human skin keratinocytes cultured in serum-free medium was investigated. TCF-P markedly inhibited the growth of keratinocytes at the concentrations >2 ng/ml under low Ca2+ conditions (0.1 mM). Growt
Because most non-melanocytic human skin cancers have p53 mutations, it is unclear whether the aberrant growth of these cancers is simply a result of the abrogation of a p53 downstream mediator, the universal cyclin-dependent kinase inhibitor p21 WAF1 . To investigate the role of p21 WAF1 in human sk
The matrix-degrading enzyme family of matrix-metalloproteinases (MMPs) has been implicated in the process of tumour metastasis. Cellular protein and RNA localisation techniques have been used to show that, whilst several MMP genes are expressed in both cancer and stromal cells, stromelysin 3 is expr